Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-22-000577
Filing Date
2022-02-01
Accepted
2022-02-01 15:33:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9169041_13-g.htm SC 13G 165068
  Complete submission text file 0000919574-22-000577.txt   166732
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91478 | Film No.: 22578643
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2828 N HARWOOD STREET SUITE 1220 DALLAS TX 75201
Business Address 2828 N HARWOOD STREET SUITE 1220 DALLAS TX 75201 214-550-1822
Avidity Partners Management LP (Filed by) CIK: 0001791827 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G